BERLIN: Germany on Tuesday raised doubts over the quality and safety of Russia's coronavirus vaccine, stressing that drug approval is granted in the European Union only after full clinical trials.
"Patient safety is of the highest priority," a health ministry spokeswoman told German newspaper network RND.
"There is no known data on the quality, efficacy and safety of the Russian vaccine."
Comments
Comments are closed for this article.